Appelhans Dannielle
Insider CIK 1874962 · HALO Director · RUBY Chief Operating Officer · GBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-09-01 | 2026-09-02 | 1,778 | — | $0 | 1,778 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-09-01 | 2026-09-02 | 1,161 | — | $0 | 1,161 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-09-01 | 2026-09-02 | 1,778 | — | $0 | 1,778 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-09-01 | 2026-09-02 | 1,161 | — | $0 | 1,161 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 2,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,840 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 6,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 736 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 1,263 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2025-06-04 | 2025-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2024-06-06 | 2024-06-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-08 | 2023-12-11 | 7,363 | $1.79 | $13.2K | 7,363 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-08 | 2023-12-11 | 637 | $1.82 | $1.2K | 12,637 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-04 | 2023-12-06 | 12,000 | $1.50 | $18.0K | 12,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2023-02-24 | 2023-02-27 | 10,385 | $0.13 | $1.4K | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-01 | 3,878 | $0.25 | $970 | 10,385 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2023-01-31 | 2023-02-01 | 7,500 | — | $0 | 22,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2023-01-31 | 2023-02-01 | 7,500 | — | $0 | 14,263 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2022-08-10 | 2022-08-12 | 5,737 | $0.80 | $4.6K | 6,763 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2022-08-09 | 2022-08-12 | 12,500 | — | $0 | 37,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2022-08-09 | 2022-08-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2022-07-15 | 2022-07-19 | 38,400 | — | $0 | 38,400 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-08-31 | 2021-09-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-08-31 | 2021-09-01 | 150,000 | — | $0 | 150,000 | SEC↗ |